Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice.
Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice.
复制标题
DOI:
10.1186/s13024-016-0128-x
复制
发表时间:
2016-09-06
影响因子:
15.1
通讯作者:
Isalan M
中科院分区:
文献类型:
--
作者:
Agustín-Pavón C;Mielcarek M;Garriga-Canut M;Isalan M
Synthetic zinc finger (ZF) proteins can be targeted to desired DNA sequences and are useful tools for gene therapy. We recently developed a ZF transcription repressor (ZF-KOX1) able to bind to expanded DNA CAG-repeats in the huntingtin (HTT) gene, which are found in Huntington’s disease (HD). This ZF acutely repressed mutant HTT expression in a mouse model of HD and delayed neurological symptoms (clasping) for up to 3 weeks. In the present work, we sought to develop a long-term single-injection gene therapy approach in the brain. Since non-self proteins can elicit immune and inflammatory responses, we designed a host-matched analogue of ZF-KOX1 (called mZF-KRAB), to treat mice more safely in combination with rAAV vector delivery. We also tested a neuron-specific enolase promoter (pNSE), which has been reported as enabling long-term transgene expression, to see whether HTT repression could be observed for up to 6 months after AAV injection in the brain. After rAAV vector delivery, we found that non-self proteins induce significant inflammatory responses in the brain, in agreement with previous studies. Specifically, microglial cells were activated at 4 and 6 weeks after treatment with non-host-matched ZF-KOX1 or GFP, respectively, and this was accompanied by a moderate neuronal loss. In contrast, the host-matched mZF-KRAB did not provoke these effects. Nonetheless, we found that using a pCAG promoter (CMV early enhancer element and the chicken β-actin promoter) led to a strong reduction in ZF expression by 6 weeks after injection. We therefore tested a new non-viral promoter to see whether the host-adapted ZF expression could be sustained for a longer time. Vectorising mZF-KRAB with a promoter-enhancer from neuron-specific enolase (Eno2, rat) resulted in up to 77 % repression of mutant HTT in whole brain, 3 weeks after bilateral intraventricular injection of 1010 virions. Importantly, repressions of 48 % and 23 % were still detected after 12 and 24 weeks, respectively, indicating that longer term effects are possible. Host-adapted ZF-AAV constructs displayed a reduced toxicity and a non-viral pNSE promoter improved long-term ZF protein expression and target gene repression. The optimized constructs presented here have potential for treating HD. The online version of this article (doi:10.1186/s13024-016-0128-x) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
16.2
作者:
Kordasiewicz HB;Stanek LM;Wancewicz EV;Mazur C;McAlonis MM;Pytel KA;Artates JW;Weiss A;Cheng SH;Shihabuddin LS;Hung G;Bennett CF;Cleveland DW
通讯作者:
Cleveland DW
影响因子:
46.9
作者:
Isalan, M;Klug, A;Choo, Y
通讯作者:
Choo, Y
影响因子:
4
作者:
Agustin-Pavon, Carmen;Isalan, Mark
通讯作者:
Isalan, Mark
DOI:
10.1073/pnas.98.4.1437
发表时间:
2001-02-13
影响因子:
11.1
作者:
Moore, M;Klug, A;Choo, Y
通讯作者:
Choo, Y
DOI:
10.1073/pnas.041616998
发表时间:
2001-02-13
影响因子:
11.1
作者:
Abrink, M;Ortiz, JA;Losson, R
通讯作者:
Losson, R